Does the world need germline editing for β-thalassemia?
Haematologica
.
2022 Jun 1;107(6):1235-1236.
doi: 10.3324/haematol.2021.279998.
Author
Andreas E Kulozik
1
Affiliation
1
Chairman, Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Hopp-Children Cancer Center Heidelberg (KiTZ).
PMID:
34706499
PMCID:
PMC9152967
DOI:
10.3324/haematol.2021.279998
No abstract available
MeSH terms
Gene Editing
Germ Cells
Humans
beta-Thalassemia* / genetics
beta-Thalassemia* / therapy